CV- ELI SCHWARTZ, MD, DTMH
LIST OF PUBLICATIONS-according to subjects (partial list)
Parasitic Diseases
Malaria:
1. Schwartz E., Golenser Y.
Treatment of malaria.
Harefu'ah, 124, 572-577, 1993.
2. Duer D., Schwartz E., Shaked N., Ramot B.
Amodiaquin-induced agranulocytosis: Drug inhibition of myloid colonies in the
presence of patient's serum.
Israel. J. of Medical Science. 21: 331-334, 1985.
3. Schwartz E., Shapiro R., Shina S., Bank, I.
Delayed Expansion of Vδ2+ and Vδ1+ γδ T cells after acute Plasmodium falciparum
and Plasmodium vivax malaria.
J. of Allergy and Clinical Immunology 97, 1387-1392, 1996.
4. Schwartz E., Pener H., Issa M.S., Golenser J.
An overview of the malaria situation in Zanzibar.
J. of Community Health 22, 33-44, 1997.
5. Golesner J., Peled-Kamar M., Schwartz E., Friedman H., Groner Y., Pollack Y.
Transgenic mice with elevated level of CuZnSOD are highly susceptible to malaria
infection.
Free Radicals Biology and Medicine .24,1504-1510,1998.
6. Schwartz E., Sidi. Y.
New aspects of malaria imported from Ethiopia.
Clinical Infectious Disease.26, 1089-1091, 1998.
7. Weber G., Schwartz E., Schlaffer F., Lang R., Alkan M.
Imported severe Plasmodium falciparum malaria in Israel.
J. of Travel Medicine. 5, 97-99, 1998.
8. Schwartz E., Samuni A., Friedman I., Hempelmann E., Golenser Y.
Deleterious role of superoxide dismutation in malaria parasites.
-1 -
Inflamation .23: 361-370, 1999.
9. Schwartz E., Regev-Yochay G.,
Primaquine as prophylaxis for malaria for non-immune travelers; comparison to
mefloquine or doxycycline
Clinical Infectious Disease. 29, 1502-1506, 1999
10. Schwartz E., Regev-Yochay G., Kurnik D.
Considering primaquine dose adjustment for radical cure of Plasmodium vivax
malaria. American . J. of Tropical Medicine and Hygiene. 62, 393-5, 2000
11. Schwartz E., Paul F., Pener H., Almog S., Rotenberg M., Golenser J.
Malaria antibodies and mefloquine levels among United Nations troops in Angola.
J. Travel Medicine. 8:113-116, 2001
12. Schwartz E. ,Potasman I.., Rotenberg M., Almog S., Sadetzki S.
Serious adverse events of mefloquine in relation to blood level and gender.
American . J. of Tropical Medicine and Hygiene. 65;189-192,2001
13. Schwartz E. Sadetzki S Murad H,. Raveh D.
Age as risk factor for severe malaria.
Clinical Infectious Diseases. 33; 1774-7, 2001
14. Schwartz E.
Primaquine for malaria prophylaxis.
In Travelers’ Malaria (P. Schlagenhauf Editor)
B C Decker Inc. Canada, 2001 (Revised 2007)
15. Potasman I, Yuven Y, Weller B, Heidecker J, Schwartz E.
Does Mefloquine Prophylaxis Affect Electro-Encephalographic Patterns?
American J. of Medicine, 112:147-149 , 2002
16. Schwartz E.,
Malaria in Israel- Can we prevent the severe morbidity and mortality ?
Harefua- (Editorial)- 141: 699-701, 2002
17. Bujanover S, Schwartz E.,
Rapid test for Malaria
Isr Med Assoc J. 4; 1167: 2002
18. Schlagenhauf P., Tschopp A., Johnson R., Nothdurft HD,Beck B., Schwartz E,
Herold M, Krebs B, Veit O, Allwinn R, Steffen R.
Tolerability of malaria chemoprophylaxis in non-immune travelers to sub-Saharan
Africa: a randomised, double-blind, four-arm study.
Br. Med. J. – 327;1078-1083, 2003
19. Schwartz E ,Bujanover S.,Kain K
Genetic Confirmation of Atovaquone–proguanil (Malarone) resistant Plasmodium
falciparum malaria acquired by a non-immune traveler to East Africa.
Clinical Infectious Diseases- 37; 450-1, 2003
-2 -
Short CV- ELI SCHWARTZ, MD, DTMH
20. Eli Schwartz, Praise M., Kozarsky P, Cetron M.
Delayed onset of malaria: Implications for chemoprophylaxis
in travelers.
New Engl. J. Med.- 349: 1510-6, 2003
21. Elliott JH, O’Brien D, Leder K, Kitchener S, Schwartz E, Weld L,
Brown GV, Torresi J. for the GeoSentinel Surveillance Network.
Imported Plasmodium vivax malaria: demographic and clinical features in
non-immune travellers
J. of Travel Medicine -11:213-219, 2004
22. Leder K, Black J, O’Brien D, Greenwood Z, Kain K, Schwartz E., Brown G,
Torresi J. Malaria in travelers: a review of the GeoSentinel Surveillance Network.
Clinical Infectious Diseases- 39:1104-12, 2004
23. Schwartz E.
Malaria – a disease that refuses to die but continues to kill.[Editorial]
Isr Med Assoc J. 2005
24. Baird K, Schwartz E, Hoffman S.
Prevention and treatment of vivax malaria.
Curr Infect Dis Rep. 9(1):39-46, 2007
25. Schlagenhauf, P, Johnson R, Schwartz E, Nothdurft HD, Steffen R.
Evaluation of mood profiles during malaria chemoprophylaxis : a randomised,
double-blind, four-arm study.
J. Travel Med- - 16(1):42-5, 2009
Schistosomiasis:
26. Schwartz E. Rozenman J, .Perelman N.
Pulmonary manifestations of early schistosoma infection among nonimmune
travelers.
American J. of Medicine 109, 718-722, 2000.
27. Schwartz E.
Pulmonary Schistosomiasis
Clinics in Chest Medicine, 23; 433-443, 2002
28. Schwartz E. Rozenman J.
Schistosomiasis
N. Engl. J. Medicine, 347;766-768, 2002
-3 -
Short CV- ELI SCHWARTZ, MD, DTMH
29. Schwartz E, Pick N, Shazberg G, Potasman I,
Hematospermia Due to Schistosome Infection in Travelers:
Diagnostic and Treatment Challenge.
Clinical Infectious Diseases. 35;1420-4, 2002
30. Schwartz E.
Hematospermia caused by schistosomiasis in travelers
[Clinical Insights, Contemporary Topics]. MD Consult Infectious Disease.
November 3, 2003. Available at: http://www.mdconsult.com
31. Schwartz E., Kozarsky P, Wilson M, Cetron MD.
Schistosome infection among river rafters on the Omo River, Ethiopia
J. of Travel Medicine – 12: 3-8, 2005
32. Meltzer E, Artom G, Marva E , Assous M, Rahav G , Schwartz E.
Schistosomiasis in travelers - new aspects of an old disease
Emerging Infectious Diseases. 12; 1696-1700, 2006
33. Schwartz E.
Lung Involvement in schistosomiasis (Chapter)
In: Om P. Sharma ed. Tropical Lung Disease 2nd edition
Taylor & Francis Group. New York, 2006
34. Meltzer E, Schwartz E.
Enteric fever: an Israeli perspective (Review)
Isr Med Assoc J. 9:736–741, 2007
35. Nicolls DJ., Weld L, Schwartz E , Reed C, Sonnenburg F, Kozarsky P, for the
GeoSentinel Surveillance Network
Schistosomiasis in Travelers: a review of patients reported to the GeoSentinel
Surveillance Network.
Am J Trop Med Hyg.79(5):729-34, 2008
36. Leshem E, Maor Y, Meltzer E, Assous M, Schwartz E.
Acute schistosomiasis outbreak: clinical features and economic impact.
Clin Infect Dis. 15;47(12):1499-506, 2008
37. Leshem E, Meltzer E, Marva E, Schwartz E,
Travel-Related Schistosomiasis Acquired in Laos
Emerging Infectious Diseases..15(11):1823-6. 2009
-4 -
Short CV- ELI SCHWARTZ, MD, DTMH
Leishmania & Myiasis:
38. Schwartz E., Gur H
D. hominis Myiasis Among Israeli Travelers to South America: An Emerging Disease in
the Amazon Basin of Bolivia.
J. of Travel Medicine 9: 97-99, 2002
39. Tamir J., Haik J., Orenstein A., Schwartz E.,
Dermatobia Hominis Myiasis among travelers returning from South America.
J. American academy of Dermatology- 48: 630-632; 2003
40. Scope A, Trau H, Andreas G., Konfino Y., Barzilay A., Schwartz E.
Experience with New World Cutaneous Leishmaniasis in Israeli Travelers.
J. Am Acad Dermatol- 49: 672-8, 2003
41. Scope A, Trau H, Bakon M, Yarom N, A. Nasereddin. Schwartz E.
Imported Mucosal Leishmaniasis in a Traveler
Clinical Infectious Diseases- 37: e83-7, 2003
42. Jeremy Tamir, Josef Haik, Eli Schwartz,
Myiasis with Lund's fly (Cordylobia rodhaini) in Travelers.
J. of Travel Medicine - 10:293-5, 2003
43. Blum J, Desjeux Ph., Schwartz E., Beck B., Hatz Ch.
Treatment of cutaneous leishmaniasis.
J. Antimicrobial Chemotherapy-53, 158-66,2004
44. Shani Adir A, Rozenman D, Kamil S, Schwartz E., Ramon M, Zalman L,
Nasereddin A, Jaffe CL, Ephros M.
Leishmania tropica in northern Israel– a clinical overview of an emerging focus
J. American academy of Dermatology -53, 810-15,2005
45. Eli Schwartz
Leishmaniasis in Israel (Editorial)
J. Israeli Military Medicine, 2005
46. Schwartz E., Hatz C, Blum J.
New World Cutaneous Leishmaniasis in Travellers
The Lancet Infectious Diseases; 6:342-9, 2006
47. Solomon M, Baum S, Barzilai A , Scope A, Trau H, Schwartz E
Liposomal Amphotericin B in comparison to Sodium Stibogluconate for
-5 -
Treatment of Cutaneous Leishmaniasis due to L. Braziliensis
J. American academy of Dermatology –56;612-616, 2007
Short CV- ELI SCHWARTZ, MD, DTMH
48. Bar Daroma E, Wilamowski A, Schnur H, Yarom N, Scheuer E, Schwartz E.
Oral Myiasis:A case report and literature review
Oral Surg Oral Med Oral Pathol Oral Radiol Endod.- 103; 92-6, 2007
49. Solomon M, , Trau H, Schwartz E
Old-World cutaneous leishmanisis: An ancient disease in wait of new drug
Annales de dermatologie et de venereologie, 135; 357-359, 2008
50. Solomon M, Baum S, Barzilai A , Pavlotzki F, Trau H, Schwartz E.
Treatment of cutaneous Leishmaniasis with Intralesional Pentostam in Israel
J Eur Acad Dermatol Venereol. (10):1189-92. 2009
Others:
51. Schwartz E., Shlim D.R.
Tick bite appendicitis (Case report).
J. of the American Medical Association. 259,24: 3561, 1988.
52. Houston R., Schwartz E.
Helmenthic infection among Peace Corp volunteers in Nepal.
J. of the American Medical Association. 263, 373-374, 1990.
53. Schwartz E., Houston R.
The effect of co-trimoxazole on stool recovery of Blastocystis hominis.
Lancet, 339, 428-429, 1992
54. Meltzer E., Perchik R, Shatzkes J. Sidi Y. Schwartz E.
Eosinophilia among returning travelers – a practical approach
American . J. of Tropical Medicine and Hygiene – 2008 ;78(5):702-9
Viral Infection
Dengue fever:
55. Schwartz E., Mendelson E., Sidi Y.
Dengue fever among travelers.
American J. of Medicine 101, 516-520, 1996.
56. Potasman I., Srugo I., Schwartz E.
Dengue seroconversion among Israeli travelers to tropical countries.
Emerging Infectious Diseases.5, 824-7,1999.
-6 -
Short CV- ELI SCHWARTZ, MD, DTMH
57. Schwartz E., Mileguir F., Grossman Z., Mendelson E .
Evaluation of serological-based diagnosis of dengue fever among travelers.
J. Clin. Virology. 19, 169-173, 2000.
58. Schwartz E. Moskovitz A.,Potasman I., Peri G., Grossman Z., Alkan M.L.
The changing epidemiology of dengue fever in travelers to Thailand.
Eur.J.Clinical Microbiology .& Infectious Diseases. 19, 784-786, 2000
59. Schwartz E.
Study of Dengue Fever among Israeli Travellers to Thailand
WHO, Dengue Bulletin, 26; 162-167, 2002
60. Wilder-Smith A, Schwartz E.
Dengue in travelers.
New Engl. J. Med – 353:924-32, 2005
61. Tanai A, Schwartz E., Bin H., Zeller H, Niedrig M, Dan M.
Chikungunia fever in Israeli travelers returning from north-western India
J. of Travel Medicine , 2008 ;15(5):382-4
62. Eli Schwartz, Leisa Weld, Wilder-Smith A, von Sonnenburg F, Keystone JS, Kain
KC, Torresi J, and Freedman DO for the GeoSentinel Surveillance Network.
Seasonality, Annual Trends, and Characteristics of Dengue in Ill Returned Travelers.
Emerging Infectious Diseases.. 2008 ;14(7):1081-8.
63. Meltzer E, Schwartz E.,
A travel medicine view of Dengue and Dengue hemorrhagic fever
Trop Med Inf Dis- (5):278-83. 2009 (Review).
Viral hepatitis:
64. Schwartz E., Shlim D.R., Innis B., Eaton M.
Viral hepatitis in foreign residents and travellers in Nepal.
J. of Wilderness Medicine. 2, 88-93, 1991.
65. Schwartz E., Yaron I., Galun E.
Hepatitis E virus (review).
Harefu'ah 127, 149-151, 1994.
66. Schwartz E., Galun E.
Prior hepatitis A virus infection enhances acute hepatitis E virus infection.
Medical Hypothesis, 42, 198-202, 1994.
-7 -
Short CV- ELI SCHWARTZ, MD, DTMH
67. Karetnyi Y.V., Favorov M.O., Khudyakova N.S., Weiss P., Bar-Shani S.,
Handsher R., Aboudy Y., Varsano N., Schwartz E., Levin E., Mendelson E.,
Fields H.A.
Serological evidence for hepatitis E infection in Israel.
J. of Medical Virology. 45, 316-320, 1995.
68. Schwartz E., Raveh D.
The prevalence of hepatitis A antibodies among Israeli travelers and the
economic feasibility of screening before vaccination
International J. of Epidemiology. 27, 118-120, 1998.
69. Schwartz E., Piper-Jenks N.
Simultaneous amebic liver abscess and hepatitis A infection.
J. of Travel Medicine. 5, 95-96, 1998.
70. Schwartz E., Piper-Jenks N. Van damme P., Galun E.
Hepatitis E virus infection among travelers.
Clinical Infectious Disease. 29, 1312-1314, 1999.
71. Piper-Jenks N. Horowitz H. Schwartz E.
The risk of hepatits E virus infection among travelers.
J. of Travel Medicine. 7, 194-99, 2000 (see attached Editorial on it)
Others:
72. Shlim D.R., Schwartz E., Houston R.
Rabies immunoprophylaxis strategy in travelers.
J. of Wilderness Medicine. 2, 15-21, 1991.
73. Gautret P, Schwartz E, Shaw M, Soula G, Gazin P. Delmont J , Parola P , Soavi
JM, Matchett E, Brown G and Torresi J for the GeoSentinel Surveillance Network.
Animal-associated injuries and related diseases among returned travellers: A
review of the GeoSentinel Surveillance Network
Vaccine- 25;2656-2663, 2007
-8 -
Short CV- ELI SCHWARTZ, MD, DTMH
Bacterial Infection
Typhoid Fever:
74. Schwartz E., Shlim D.R., Eaton M., Jenks N., Houston R.
The effect of oral and parenteral typhoid vaccination on the rate of infection with
Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal.
Archives of Internal Medicine. 150, 349-51, 1990.
75. Schwartz E., Shlim D.R.
Enteric fever among Israeli travellers in Nepal: The need for typhoid vaccination.
Israel. J. of Medical Science. 26, 325-27, 1990.
76. Schwartz E.
Typhoid vaccine - a double-edged sword?
Israel. J. of Medical Science. 26, 645-46, 1990
77. Schwartz E., Piper Jenks N., Shlim DR.,
Typhoid hepatitis or typhoid fever and acute viral hepatitis.
Transactions of the Royal Society of Tropical Medicine and Hygiene.88:437-438,
1994.
78. Shlim D.R., Schwartz E., Eaton M.
Clinical importance of Salmonella paratyphi A infection to enteric fever in Nepal.
J. of Travel Medicine 2, 1665-168, 1996.
79. Meltzer E., Sadik C, Schwartz E.
Enteric Fever in Israeli Travelers: a Nation-Wide study
J. of Travel Medicine – 12:275-81 , 2005
80. Meltzer E. Yosipovitch O., Sadik C., Dan M, Schwartz E.
Epidemiology and clinical aspects of Typhoid Fever in Israel.
American . J. of Tropical Medicine and Hygiene 74; 540-45, 2006
81. Meltzer E, Schwartz E.
Typhoid fever in Israel (Review)
Isr Med Assoc J. 9:736–741, 2007
82. Connor BA, Schwartz E.
Typhoid and paratyphoid fever in Travellers
The Lancet Infectious Diseases-5,623-8, 2005
-9 -
Short CV- ELI SCHWARTZ, MD, DTMH
83. Meltzer E, Schwartz E.
Enteric fever: an Israeli perspective (Review)
Isr Med Assoc J. 9:736–741, 2007
84. Schwartz E. Connor BA.
Typhoid infection.
BMJ Point-of-Care ;2008 www.pointofcare.bmj.com
Spirochete (Leptospirosis & Relapsing Fever)
85. Kariv R, Klempfner R., Barnea A. Sidi Y, Schwartz E.
The changing epidemiology of leptospirosis in Israel.
Emerging Infectious Diseases. 7; 990- 992, 2001
86. Hadad E.,Pirogovsky A, Bartal C, Gilad J, Barnea A, Itzhaki S, Grotto I,
Balicer R, Schwartz E.
Leptospirosis among Israeli troops trained in the Jordan river.
American . J. of Tropical Medicine and Hygiene –74: 127-31, 2006
87. Sidi G, Balicer R, , Davidovitch N, Anis E, Grotto I, Schwartz E.
The Epidemiology of Tick-Borne Relapsing Fever in Israel
Emerging Infectious Diseases. 11; 1784-6, 2005
88. Hadad E.,Pirogovsky A, Bartal C, Gilad J, Barnea A, Itzhaki S, Grotto I,
Balicer R, Schwartz E.
Leptospirosis among Israeli troops trained in the Jordan river.
American . J. of Tropical Medicine and Hygiene –74: 127-31, 2006
89. Sidi G, Balicer R, , Davidovitch N, Grotto I, Schwartz E.
Tick-Borne Relapsing Fever in Israeli Defence Forces
J. Israel Miltary Medicine., 3; 51-55, 2006
90. Leshem E, Segal G, Barnea A, Yitzhaki S. , Ostfeld I , Pitlik S, Schwartz E.
Travel-Related Leptospirosis in Israel: A Nationwide Study
Am J Trop Med Hyg. 2010- In press
Others:
91. Fanny D., Thomas L., Schwartz E.
An outbreak of pyomyositis in a large refugee camp in Thailand.
American . J. of Tropical Medicine and Hygiene. 33: 131-133, 1982.
-10 -
Short CV- ELI SCHWARTZ, MD, DTMH
92. Somekh E., Lev B., Schwartz E., Barzilai A., Rubinstein E.
The effect of ciprofloxacin and pefloxacin on bone marrow engraftment in the spleen of
mice.
J. of Antimicrobial Chemotherapy. 23:247-51, 1989
93. Moualem M., Friedman E., Pausner R., Schwartz E., Rubinstein E.:
Rickettsiosis- associated hyponatremia.
Infection 15,5: 315-316, 1987.
94. Schwartz E, Bar-El D, Schur N.
The History of Cholera Epidemics in Israel
Harefuah,-144:, 363-70, 2005
95. Jensenius M, Davis X, Sonnenburg F, Schwartz E,. Keystone JS, Leder K, LopézVéléz R, Caumes E,. Cramer JP, Chen L, Parola P, for the GeoSentinel Surveillance
Network*
Rickettsial diseases in international travellers: the GeoSentinel
experience 1996-2008
Emerging Infectious Diseases.. 2009
96. Meltzer E, Sidi Y, Smolen G, Banai M, Schwartz E
Sexually transmitted Brucellosis in humans
Clin Infect Dis. 2010 –in press
International Missions
97. Schwartz E., Pener H., Issa M.S., Golenser J.
An overview of the malaria situation in Zanzibar.
J. of Community Health 22, 33-44, 1997.
98. Schwartz E., Paul F., Pener H., Almog S., Rotenberg M., Golenser J.
Malaria antibodies and mefloquine levels among United Nations troops in Angola.
J. Travel Medicine. 8:113-116, 2001
99. Schwartz E.
Help Tsunami Victims – be a Tourist!
J. of Travel Medicine , 12; 120-21, 2005
100. Schwartz E.
The aftermath of the Tsunami
Harefuah,- 144: 160-162, 2005
101. Katz U, Zilberman N, Rusinek I, Schwartz E
-11 -
Israeli mission to Equatorial Guinea during a cholera outbreak
Harefuah,-, 144:, 306-9, 2005
102. Katz U, Zilberman N, Rusinek I, Schwartz E
Caring for the Care-givers
J. of Travel Medicine , 13; 63-6, 2006
Travel Medicine –Epidemiology & general
103. The GeoSentinel Group. Geosentinel:The Global Emerging Infections Sentinel
Network of the International Society of Travel Medicine.
J. of Travel Medicine. 6: 94-98, 1999.
104.Alkan M.L., Hermesh H., Simerman J., Atzmon B., Peri G., Schwartz E..
Severe psychiatric disorders during trips to the Far East.
Harefu’a . 136, 940-942, 1999.
105.Schwartz E. Witztum E., Mumcuoglu K.Y
Travel as a trigger for shared delusional parasitosis.
Travel Medicine. 8;26-28, 2001
106. M.E. Wilson, Eli Schwartz
Fever in returening travelers. (Chapter)
In: Keystone JS, ed. Travel Medicine. Edinburgh: Mosby 2004
107. Steinlauf S, Segall G, Sidi Y, Schwartz E
Epidemiology of Travel -Related Hospitalization
J. of Travel Medicine – 12: 136-141, 2005
108. Wilson ME, Weld L Boggild A, Keystone JS., Kain KC, Sonnenburg F,
Schwartz E for the GeoSentinel Surveillance Network
Fever in Returned Travelers :Results from the GeoSentinel Surveillance
Network Clinical Infectious Diseases-, 44 (12) 1560-8. 2007
109. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F,
Keystone JS, Pandey P, Cetron MS; GeoSentinel Surveillance Network.
Spectrum of disease and relation to place of exposure among ill returned travelers.
N Engl J Med. ;354:119-30. 2006
110. Wilson ME, Weld L Boggild A, Keystone JS., Kain KC, Sonnenburg F, Schwartz E
Fever in Returned Travelers :Results from the GeoSentinel Surveillance Network
Clinical Infectious Diseases-, 44 (12) 1560-8. 2007
111. Greenwood Z , Black J Weld L, O’Brien D, Leder K, Von Sonnenburg F,
Pandey P, Schwartz E, Connor B, Brown G, Freedman D, Torresi J, for the
GeoSentinel Surveillance Network.
Gastrointestinal Infection Among International Travelers Globally
J. of Travel Medicine , 15(4):221-8. ; 2008
-12 -
Short CV- ELI SCHWARTZ, MD, DTMH
112. Lederman E, Weld L, Elyazar I, Kes M , Sonnenburg F, Loutan L, Schwartz E.
Keystone J.
Dermatologic Conditions of the Ill Returned Traveler: An Analysis from the
GeoSentinel Surveillance Network”
Int J Infect Dis. 12(6):593-602; 2008
113. Leshem E, Pandey P.,. Shlim DR, Hiramatsu K, Sidi Y , Schwartz E
Clinical Features of Patients with Severe Altitude Illness in Nepal
J. Travel Med- 15(5):315-22. 2008
114. Nicolls DJ., Weld L, Schwartz E , Reed C, Sonnenburg F, Kozarsky P, for the
GeoSentinel Surveillance Network
Schistosomiasis in Travelers: a review of patients reported to the GeoSentinel
Surveillance Network.
Am J Trop Med Hyg. 79(5):729-34. 2008
115. Steinlauf S, Yahalom, Schwartz E , Shinar E, Segal G, Sidi Y
Epidemiology of HTLV1 infection among blood donors in Israel: A Global
Implication?
Emerging Infectious Diseases.. 15(7):1116-8. 2009
116. Hagmann S, , Neugebauer R, , Schwartz E, Perret C, Castelli F, Barnett E, Stauffer
WM., for the GeoSentinel Surveillance Network*
Illness in Children after International Travel:Analysis from the GeoSentinel
Surveillance Network
Pediatrics -accepted
117. Chen LH., Wilson ME., Davis X, Loutan L, Schwartz E, Keystone J, Hale D, Lim PL,
McCarthy A, Gkrania-Klotsas E, Schlagenhauf P, for the GeoSentinel Surveillance
Network
Risk of illness in long-term travelers presenting to the GeoSentinel Surveillance
Network
Emerging Infectious Diseases.. 15(11):1773-82. 2009
118. Schlagenhauf P,. Chen LH,. Wilson ME , Freedman DO, Tcheng D., Schwartz E,
Pandey P, Weber R, Nadal D, Berger C, Sonnenburg F, Keystone J, Leder K.
Sex and Gender Differences in Travel-Associated Illness
Clin Infect Dis. 50(6):826-832; 2010
-13 -
-14 -